Sakai Chemical Industry Co., Ltd. (TYO:4078)
Japan · Delayed Price · Currency is JPY 3,100.00
-125.00 (-3.88%)
Nov 6, 2026, 3:30 PM JST
Sakai Chemical Industry Financials Overview
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 82,777 | 81,447 | 84,409 | 82,105 | 83,861 | 80,135 |
Revenue Growth | 0.12% | -3.51% | 2.81% | -2.09% | 4.65% | -5.63% |
Gross Profit Gross Profit Growth | 20,553 | 20,705 | 20,282 | 16,857 | 18,480 | 21,045 |
Operating Income Operating Income Growth | 6,254 | 6,453 | 6,094 | 2,943 | 4,408 | 7,495 |
Net Income Net Income Growth | 3,470 | 2,752 | 5,013 | -7,092 | 2,344 | 6,747 |
Earnings Per Share EPS Growth | 200.09 | 157.55 | 278.91 | -437.64 | 144.81 | 407.06 |
EPS Growth | -26.21% | -43.51% | - | - | -64.43% | - |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Titanium Oxide and Zinc Products Titanium Oxide and Zinc Products Growth | 9,678 | 10,509 | 13,470 | - | - | - |
Sanitary Materials Sanitary Materials Growth | 5,498 | 5,353 | 5,623 | - | - | - |
Contract Processing Contract Processing Growth | 7,081 | 6,948 | 6,733 | - | - | - |
Resin Additives Resin Additives Growth | 11,626 | 11,525 | 13,081 | - | - | - |
Organic Chemicals Organic Chemicals Growth | 6,996 | 7,197 | 6,672 | - | - | - |
Electronic Materials Electronic Materials Growth | 11,871 | 11,377 | 10,014 | - | - | - |
Cosmetic Materials Cosmetic Materials Growth | 1,917 | 1,720 | 2,676 | - | - | - |
Others Others Growth | 11,489 | 10,606 | 10,297 | - | - | - |
Unallocated Adjustment Unallocated Adjustment Growth | -1,666 | -1,745 | -2,656 | -1,122 | -1,027 | -1,713 |
Catalyst Catalyst Growth | 3,766 | 3,565 | 3,226 | - | - | - |
Inorganic Material Inorganic Material Growth | - | 5,997 | 6,750 | - | - | - |
Medical Medical Growth | - | 8,391 | 8,518 | 8,240 | 8,139 | 8,185 |
Total Total Growth | 82,772 | 81,443 | 84,404 | 82,106 | 83,861 | 80,136 |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 17,724 | 15,502 | 16,183 | 16,590 | 12,409 | 10,800 |
Total Debt Total Debt Growth | 12,524 | 16,000 | 21,918 | 27,038 | 21,642 | 16,958 |
Net Cash (Debt) Net Cash Growth | 5,200 | -498 | -5,735 | -10,448 | -9,233 | -6,158 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | 299.81 | -28.51 | -319.04 | -644.74 | -570.40 | -371.52 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | - | 14,479 | 12,005 | 6,866 | 773 | 6,567 |
Capital Expenditures CapEx Growth | - | -6,070 | -6,948 | -4,024 | -2,658 | -5,064 |
Free Cash Flow Free Cash Flow Growth | - | 8,409 | 5,057 | 2,842 | -1,885 | 1,503 |
Free Cash Flow Growth | - | 66.28% | 77.94% | - | - | - |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 24.83% | 25.42% | 24.03% | 20.53% | 22.04% | 26.26% |
Operating Margin | 7.56% | 7.92% | 7.22% | 3.58% | 5.26% | 9.35% |
Pretax Margin | 6.65% | 5.53% | 7.07% | -4.51% | 5.93% | 11.51% |
Profit Margin | 4.19% | 3.38% | 5.94% | -8.64% | 2.79% | 8.42% |
FCF Margin | - | 10.32% | 5.99% | 3.46% | -2.25% | 1.88% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 7, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 160.000 | 145.000 | 135.000 | 70.000 | 75.000 | 70.000 |
Dividend Per Share Growth | 16.36% | 7.41% | 92.86% | -6.67% | 7.14% | 366.67% |
Dividend Yield | 5.16% | 4.19% | 4.98% | 3.62% | 4.24% | 3.60% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 7, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 15.49 | 19.25 | 8.76 | - | 12.23 | 4.66 |
Forward PE | 11.51 | 12.44 | 9.29 | 28.35 | 6.36 | 7.40 |
P/FCF Ratio | 5.86 | 6.30 | 8.69 | 11.03 | - | 20.90 |
PS Ratio | 0.60 | 0.65 | 0.52 | 0.38 | 0.34 | 0.39 |